Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis

BACKGROUND: Aclidinium bromide is a new long-acting muscarinic antagonist (LAMA) indicated for maintenance bronchodilator treatment of chronic obstructive pulmonary disease (COPD). The efficacy of aclidinium was compared with tiotropium and glycopyrronium, using a network meta-analysis (NMA) of rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabis, Andreas, Lindner, Leandro, Mocarski, Michelle, Huisman, Eline, Greening, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772873/
https://www.ncbi.nlm.nih.gov/pubmed/24043936
http://dx.doi.org/10.2147/COPD.S48967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772873/
https://www.ncbi.nlm.nih.gov/pubmed/24043936
http://dx.doi.org/10.2147/COPD.S48967

Ejemplares similares